Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
Recruiting
Phase 4
Interventional Study
Shivering
Dose Finding Study
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women presenting for planned cesarean delivery.
* American Society of Anesthesiology Physical Classification Status 2 or 3; without major medical co-morbidities.
* Singleton gestation in the 3rd trimester (28-42 weeks gestation).
* Spinal anesthesia technique Women presenting …
Contacts